Cargando…
Analysis of curative effect of I(125) implantation combined with radiofrequency ablation in treating bone metastases
The aims of this study were to investigate the clinical effects of I(125) implantation combined with radiofrequency ablation in treating bone metastases (BM) and analyze its clinical application so as to provide better treatment protocols for the treatment of BM. A total of 63 BM patients were rando...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993946/ https://www.ncbi.nlm.nih.gov/pubmed/29892521 http://dx.doi.org/10.1016/j.jbo.2018.01.001 |
_version_ | 1783330322852610048 |
---|---|
author | Zhang, Qizhou Zhang, Kunyao Xie, Bing Ren, Yimin Li, Guoliang Zhang, Liping Wang, Aijing Li, Yang |
author_facet | Zhang, Qizhou Zhang, Kunyao Xie, Bing Ren, Yimin Li, Guoliang Zhang, Liping Wang, Aijing Li, Yang |
author_sort | Zhang, Qizhou |
collection | PubMed |
description | The aims of this study were to investigate the clinical effects of I(125) implantation combined with radiofrequency ablation in treating bone metastases (BM) and analyze its clinical application so as to provide better treatment protocols for the treatment of BM. A total of 63 BM patients were randomly divided into the I(125) implantation group (CON, treated with I(125) seeds alone, 33 patients) and the combination group (I(125)-MA, 30 patients) to compare the clinical efficacy and adverse effects. After treatment, the clinical efficacy of Group I(125)-MA was significantly better than Group CON, and the quality of life was improved significantly (P< 0.05). I(125)-MA has relatively better clinical efficacy in treating BM, which can not only significantly improve patients’ life quality but also cause no serious adverse reaction. The therapy of I(125) implantation combined with radiofrequency ablation provides a new idea for treating bone metastases. Compare Group I(125)-MA and Group CON, remission rates of bone pain were 76.7% vs 42.4% (P< 0.05); movement ability: 73.3% vs 39.4% (P< 0.05); quality of life: improvement rates: 70% vs 42.4% (P< 0.05), the median initial time of relieve pain: 3.5 days vs 7.6 days (P< 0.05). |
format | Online Article Text |
id | pubmed-5993946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-59939462018-06-11 Analysis of curative effect of I(125) implantation combined with radiofrequency ablation in treating bone metastases Zhang, Qizhou Zhang, Kunyao Xie, Bing Ren, Yimin Li, Guoliang Zhang, Liping Wang, Aijing Li, Yang J Bone Oncol Research Article The aims of this study were to investigate the clinical effects of I(125) implantation combined with radiofrequency ablation in treating bone metastases (BM) and analyze its clinical application so as to provide better treatment protocols for the treatment of BM. A total of 63 BM patients were randomly divided into the I(125) implantation group (CON, treated with I(125) seeds alone, 33 patients) and the combination group (I(125)-MA, 30 patients) to compare the clinical efficacy and adverse effects. After treatment, the clinical efficacy of Group I(125)-MA was significantly better than Group CON, and the quality of life was improved significantly (P< 0.05). I(125)-MA has relatively better clinical efficacy in treating BM, which can not only significantly improve patients’ life quality but also cause no serious adverse reaction. The therapy of I(125) implantation combined with radiofrequency ablation provides a new idea for treating bone metastases. Compare Group I(125)-MA and Group CON, remission rates of bone pain were 76.7% vs 42.4% (P< 0.05); movement ability: 73.3% vs 39.4% (P< 0.05); quality of life: improvement rates: 70% vs 42.4% (P< 0.05), the median initial time of relieve pain: 3.5 days vs 7.6 days (P< 0.05). Elsevier 2018-01-08 /pmc/articles/PMC5993946/ /pubmed/29892521 http://dx.doi.org/10.1016/j.jbo.2018.01.001 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Zhang, Qizhou Zhang, Kunyao Xie, Bing Ren, Yimin Li, Guoliang Zhang, Liping Wang, Aijing Li, Yang Analysis of curative effect of I(125) implantation combined with radiofrequency ablation in treating bone metastases |
title | Analysis of curative effect of I(125) implantation combined with radiofrequency ablation in treating bone metastases |
title_full | Analysis of curative effect of I(125) implantation combined with radiofrequency ablation in treating bone metastases |
title_fullStr | Analysis of curative effect of I(125) implantation combined with radiofrequency ablation in treating bone metastases |
title_full_unstemmed | Analysis of curative effect of I(125) implantation combined with radiofrequency ablation in treating bone metastases |
title_short | Analysis of curative effect of I(125) implantation combined with radiofrequency ablation in treating bone metastases |
title_sort | analysis of curative effect of i(125) implantation combined with radiofrequency ablation in treating bone metastases |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993946/ https://www.ncbi.nlm.nih.gov/pubmed/29892521 http://dx.doi.org/10.1016/j.jbo.2018.01.001 |
work_keys_str_mv | AT zhangqizhou analysisofcurativeeffectofi125implantationcombinedwithradiofrequencyablationintreatingbonemetastases AT zhangkunyao analysisofcurativeeffectofi125implantationcombinedwithradiofrequencyablationintreatingbonemetastases AT xiebing analysisofcurativeeffectofi125implantationcombinedwithradiofrequencyablationintreatingbonemetastases AT renyimin analysisofcurativeeffectofi125implantationcombinedwithradiofrequencyablationintreatingbonemetastases AT liguoliang analysisofcurativeeffectofi125implantationcombinedwithradiofrequencyablationintreatingbonemetastases AT zhangliping analysisofcurativeeffectofi125implantationcombinedwithradiofrequencyablationintreatingbonemetastases AT wangaijing analysisofcurativeeffectofi125implantationcombinedwithradiofrequencyablationintreatingbonemetastases AT liyang analysisofcurativeeffectofi125implantationcombinedwithradiofrequencyablationintreatingbonemetastases |